Publications

Export 33 results:
Author Title Type [ Year(Asc)]
Filters: Author is Bruno Giros  [Clear All Filters]
2021
Bhardwaj SK, Cui Q, Moquin L, Gratton A, Giros B, Srivastava LK.  2021.  Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.. Neuropharmacology. 184:108440.
2020
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Cutando L, Puighermanal E, Castell L, Tarot P, Bertaso F, Bonnavion P, d'Exaerde Ade Kerchov, Isingrini E, Galante M, Dallérac G et al..  2020.  Regulation of GluA1 phosphorylation by d-amphetamine and methylphenidate in the cerebellum.. Addict Biol. :e12995.
2019
Orrico-Sanchez A, Chausset-Boissarie L, de Sousa RAlves, Coutens B, Amin SRezai, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T et al..  2019.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.. Mol Psychiatry.
Cavarec F, Krauss P, Witkowski T, Broisat A, Ghezzi C, De Gois S, Giros B, Depaulis A, Deransart C.  2019.  Early reduced dopaminergic tone mediated by D3 receptor and dopamine transporter in absence epileptogenesis.. Epilepsia. 60(10):2128-2140.
Nair AG, Castro LRV, Khoury MEl, Gorgievski V, Giros B, Tzavara ET, Hellgren-Kotaleski J, Vincent P.  2019.  The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.. Neuropharmacology. 146:74-83.
Giguère N, Delignat-Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, Anand-Srivastava M, Gether U, Giros B, Trudeau L-É.  2019.  Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.. PLoS Genet. 15(8):e1008352.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å.  2019.  The NeuroD6 Subtype of VTA Neurons Contributes to Psychostimulant Sensitization and Behavioral Reinforcement.. eNeuro. 6(3)
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu AP, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM et al..  2019.  Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration.. Sci Rep. 9(1):7850.
2018
Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JPablo, Grenier J, Ibrahim EChérif, Khoury M-AEl, Tse YC, Mongredien R et al..  2018.  Antidepressive effects of targeting ELK-1 signal transduction.. Nat Med. 24(5):591-597.
Giros B.  2018.  [Biological psychiatry v3.0].. Med Sci (Paris). 34(11):899-900.
Petrelli F, Dallérac G, Pucci L, Calì C, Zehnder T, Sultan S, Lecca S, Chicca A, Ivanov A, Asensio CS et al..  2018.  Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.. Mol Psychiatry.
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM et al..  2018.  Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor.. Neuroimage. 176:226-238.
2017
Santos MDos, Cahill EN, Dal Bo G, Vanhoutte P, Caboche J, Giros B, Heck N.  2017.  Cocaine increases dopaminergic connectivity in the nucleus accumbens.. Brain Struct Funct.
C Filho DDe Magalha, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C, Nosten-Bertrand M, Billard J-M, Blaise A, Tronche F et al..  2017.  Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.. J Cereb Blood Flow Metab. 37(2):396-412.
Isingrini E, Guinaudie C, Perret LC, Rainer Q, Moquin L, Gratton A, Giros B.  2017.  Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.. Sci Rep. 7(1):12432.
Fasano C, Rocchetti J, Pietrajtis K, Zander J-F, Manseau F, Sakae DY, Marcus-Sells M, Ramet L, Morel LJ, Carrel D et al..  2017.  Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells.. Front Cell Neurosci. 11:140.
Erdozain AM, De Gois S, Bernard V, Gorgievski V, Pietrancosta N, Dumas S, Macedo CE, Vanhoutte P, Ortega JE, J Meana J et al..  2017.  Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.. Neuropsychopharmacology.
Xu Y, Lu Y, Xu P, Mangieri LR, Isingrini E, Xu Y, Giros B, Tong Q.  2017.  VMAT2-Mediated Neurotransmission from Midbrain Leptin Receptor Neurons in Feeding Regulation.. eNeuro. 4(3)
2016
Isingrini E, Perret L, Rainer Q, Amilhon B, Guma E, Tanti A, Martin G, Robinson J, Moquin L, Marti F et al..  2016.  Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons.. Nat Neurosci. 19(4):560-3.
Isingrini E, Perret L, Rainer Q, Sagueby S, Moquin L, Gratton A, Giros B.  2016.  Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.. J Psychiatry Neurosci. 41(3):169-81.
2015
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet A-M, Gardier AM, Schinkel AH, Giros B et al..  2015.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.. Mol Psychiatry. 20(7):889-900.
De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B.  2015.  Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.. J Biol Chem. 290(29):17848-62.

Pages